Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,035
Closed -$41K 266
2021
Q1
$41K Hold
2,035
0.01% 393
2020
Q4
$55K Buy
+2,035
New +$45.7K 0.03% 250
2020
Q3
Sell
-1,904
Closed -$34K 270
2020
Q2
$34K Buy
+1,904
New +$29K 0.03% 264
2019
Q4
$22K Buy
+1,304
New +$17.4K 0.02% 306

Other funds holding CLLS

RMR Wealth Builders's CLLS Position: Q2 2021 in Review

RMR Wealth Builders sold out of Cellectis (CLLS) in Q2 2021, closing a stake of 2,035 shares — an estimated $41K sold.

RMR Wealth Builders first reported a position in CLLS in Q4 2019 and held it in 4 quarters. The position peaked at $55K in Q4 2020. 78 funds tracked by Wall St. Rank hold CLLS as of Q2 2021.

  • RMR Wealth Builders reported no remaining Cellectis position as of Q2 2021 after selling out during the quarter.
  • RMR Wealth Builders sold 2,035 Cellectis shares in Q2 2021, an estimated $41K.
  • RMR Wealth Builders first reported a position in Cellectis in Q4 2019 and held it in 4 quarters.
  • RMR Wealth Builders's Cellectis position peaked at $55K in Q4 2020.
  • 78 funds tracked by Wall St. Rank held Cellectis as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.